Functional and Mechanistic Explanation for the Unique Clinical Success of the Glucokinase Activator Dorzagliatin in the Treatment of Type 2 Diabetes
Consortia: HPAC
Roman J, Yuan Y, Xu Y, Zhu Q, Wu S, Zhao F, Zhou X, Meng S, Han D, Sharp K, Chen L, Li C, Doliba NM.
Diabetes. 2025 Aug 1;74(8):1374-1384. doi: 10.2337/db25-0066. PMID:40272935